Contact Us
The form has been submitted successfully!
There has been some error while submitting the form. Please verify all form fields again.
Contact us for any questions or enquiries.
Address
111, North Bridge Road,
Peninsula Plaza #21-01,
Singapore 179098
Singapore
Company UEN: 202449203E
+65 88495493
info@gilms.org
Dr. Markus U. Boehnert, MD, PhD, MBA, FACS
Associate Professor of Surgery | Director, Living Donor Liver Transplant Program
King Faisal Specialist Hospital & Research Center, Riyadh | Erasmus University, Rotterdam
Dr. Markus U. Boehnert is a distinguished transplant surgeon and academic leader specializing in liver transplantation and hepatopancreatobiliary (HPB) surgery. With over two decades of experience spanning Germany, Switzerland, Canada, the Netherlands, and Saudi Arabia, he has made significant contributions to advancing surgical techniques and transplant medicine.
Dr. Boehnert obtained his medical and dental degrees from Friedrich Alexander University, Germany, followed by specialized training in visceral and transplant surgery at the University of Berne, Switzerland. He further honed his expertise as a clinical fellow at Toronto General Hospital’s Multi-Organ Transplant Program. His academic credentials include a PhD from Semmelweis University, Hungary, and an MBA from Leuphana University, Germany.
Currently, Dr. Boehnert serves as the Director of the Living Donor Liver Transplant Program at King Faisal Specialist Hospital & Research Center, Riyadh. He is also an Associate Professor of Surgery at Erasmus University, Rotterdam, where he mentors future medical leaders. His research focuses on organ preservation, ischemia-reperfusion injury, and machine perfusion technologies, earning him prestigious grants, including multi-million-dollar funding from Saudi Arabia’s National Science, Technology, and Innovation Plan.
A thought leader in transplantation, Dr. Boehnert has received numerous awards, including the Young Investigator Award and Basic Science Trainee Award. He has contributed extensively to peer-reviewed journals and serves as an independent reviewer for leading medical publications. As a globally recognized speaker, he has been invited to major international conferences to share insights on liver transplantation advancements.
With an unwavering commitment to surgical excellence, research, and education, Dr. Boehnert continues to shape the future of transplant medicine.
Dr. Md Misbahul Ferdous, PhD, Cardiology
Dr. Md Misbahul Ferdous is a highly accomplished interventional cardiologist with extensive experience in cardiovascular diagnostics, treatment, and research. Holding a PhD in Cardiology from Shandong University School of Medicine and serving as a Post-Doctoral Fellow at Peking Union Medical College, Beijing, Dr. Ferdous has established himself as a leader in the field. His expertise spans a wide range of interventional procedures, including diagnostic catheterization, transcatheter aortic valve implantation (TAVI), intravascular ultrasound (IVUS/OCT), fractional flow reserve (FFR/IFR), and percutaneous coronary intervention (PCI). He is also proficient in advanced echocardiography techniques such as TTE, TEE, TSE, and DSE.
Dr. Ferdous has held prestigious fellowships at renowned institutions, including Fuwai Hospital in Beijing and Ageo Central General Hospital in Japan. During his tenure, he managed complex cases, performed intricate procedures, and worked with hemodynamic support devices like Impella and IABP. His clinical acumen extends to advanced heart failure management, cardiac imaging (CT and MRI), and ICD/pacemaker programming.
A dynamic leader, Dr. Ferdous has served in key roles such as Deputy Director of the Kunming Yundi Behavior and Health Research Center, Vice President of the Asia Pacific Primary Health Association, and Vice President of the Asian Society of Cardiology. He has also led international clinical surveys, coordinating efforts across 216 hospitals in nine countries. His editorial contributions include serving as an Associate Editor for the US Cardiology Review Journal and authoring high-impact research papers in leading journals such as CELLS (Impact Factor: 7.66) and Advances in Therapy (Springer Nature, Impact Factor: 3.8).
Dr. Ferdous is a sought-after speaker, having presented at over 40 international conferences, including the prestigious TCT 2019 in the USA. His research focuses on innovative treatments, such as bioresorbable vascular scaffolds and bivalirudin use in PCI, contributing significantly to the advancement of cardiology.
With strong communication skills, attention to detail, and a commitment to excellence, Dr. Ferdous continues to drive progress in cardiovascular care. His work bridges clinical practice, research, and global health leadership, making him a distinguished figure in the medical community.
He believes towards” ONE BELT ONE ROAD ONE HEART“.
Dr Mustafa Ali Mohd
Dr. Mustafa was a professor in the Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia. He was also the Deputy Dean, faculty of Medicine, University of Malaya, and then as Deputy Director of University of Malaya Medical Centre (UMMC).
As an academic, he was promoted to Professor grade A (JUSA A) in the University of Malaya and he was awarded Fellow of the Malaysian Academy of Science and he was also awarded Top Research Scientist of Malaysia in 2012 by the same academy. Prior to this, he was also awarded Excellent scientist award by the Malaysian Ministry of Education in 2005.
He was also in the panel member of consultants to the World Health Organisation (WHO) in several occasions to help in major world crisis such as during the global contamination of melamine in food and food products, and also on issues pertaining to the use and safety of bisphenol A in babies feeding bottles.
He was appointed as a Member of College of Experts Reviewers, European Foundation of Science (EFS). He is an academic advisor to HESTIC (Health, Environment, Science, Technology International Consultant), Tokyo, Japan. He is the founder member, Senior consultant and Director of the Shimadzu UMMC Centre for Xenobiotics Studies in the Faculty of Medicine, University of Malaya.
Since the early years of his career he has conducted extensive research in various disciplines such as Herbal Medicine, toxicology, drugs of abuse, food safety, environmental Health, occupational health, analytical techniques in identification of toxic chemicals and endocrine disrupting chemicals. He was also National Project coordinator for the “United Nations University on Environmental monitoring, analysis and governance in East Asia: Technology Transfer” based in Tokyo, Japan. He was also a member of the Malaysian National Food Safety council.
Prof. Dr. Relawati HMS
Prof. Dr. Relawati HMS has cultivated 30 years of expansive Business Network in Asia leveraging her extensive expertise and insights for Global Future Business Management. She is well-versed in the Information Technology and Digital Markets. Her immense experience in the Service Industry shows in all her actions and efforts and most of all her commitment to ensuring the best for all involved.
Dr. Relawati is the Director and Singapore President of the Universal Institute of Professional Management (UIPM). A Singapore-based registered organization, operating globally under the esteemed Singapore brand and accredited by reputable international agencies. UIPM stands as a beacon of excellence in online education, offering a diverse array of courses and programs designed to empower students to learn at their own pace and convenience.
She is also Singapore’s Country Director for UNITED PEACE KEEPERS FEDERAL COUNCIL, an International Non-Governmental Charitable, Humanitarian and Peace Organization that collaborates and implements programs and activities that support the United Nations Sustainable Development Goals, with the primary focus on Peace, Justice, Equality and Peaceful coexistence globally.
Prof Dr. Rasheed AG
Prof Dr. Rasheed has been on a remarkable business journey spanning over 30 years, marked by both successes and challenges that have shaped his expertise. He began his career in his family’s business, where he gained invaluable lessons and a deep understanding of the dynamics of the business world. Over the years, he has cultivated a vast network of business connections, establishing meaningful relationships with partners and friends across the globe.
Drawing from his extensive experience and global insights, he now offers consultancy services to help businesses navigate complexities and grow. He also offer to his close business associates his wisdom and unique perspective.
In addition to his business acumen, he is an NLP Practitioner, deeply passionate about psychology and metaphysics. This knowledge allows him to approach his work with a profound understanding of human behavior, adding a unique layer to his consultancy.
He is deeply passionate about the health challenges facing the world today and believes that by sparking a movement in awareness, we can inspire a transformative shift in how we live life. His goal is to create a mission where through knowledge and awareness, one can potentially make more informed choices about the foods they consume, develop a profound understanding of their bodies, and prioritize well-being in every decision.
Currently, he serves as the Director of Global Institute for Leadership and Management, Singapore Pte. Ltd(GILMS) and UIPM Singapore LLP, and an online Institution dedicated to empowering professionals through education and personal development. His leadership reflects his commitment to fostering growth and inspiring others on their own professional journeys.
Prof. Dr. Md. Bipul Nazir is an internationally recognized expert in REGENactive therapy, lifestyle management, and longevity. With a career that spans over a decade, he has established himself as a thought leader and innovator in the field of wellness, advocating for a holistic approach to health that emphasizes the importance of nutrition, preventive care, and natural healing methods. Prof. Nazir began his journey in healthcare and wellness in 2009, focusing on the concept of early detection. He strongly encouraged individuals to undergo comprehensive health screenings as a preventive measure, laying the foundation for his future work in REGENactive therapy and wellness. Over the years, his dedication to understanding and improving human health led him to master and advocate for REGENactive therapy — a cutting-edge approach to healing that combines advanced technology with the body’s natural ability to regenerate and restore itself. In his pursuit of excellence, Prof. Nazir has forged connections with prestigious organizations such as the World Health Organization (WHO), UIPM Singapore, and the Global Research Institute. His work has gained international recognition, particularly in the development of wellness protocols that have been adopted globally.
Prof. Nazir’s vision for human longevity is ambitious yet grounded in scientific research. He believes that with the right lifestyle choices and a focus on maintaining optimal health, individuals can live a fit, healthy, and fulfilling life, free from disease, up to the age of 130. This belief is not merely theoretical; it is supported by his extensive research and practical innovations in the field of wellness.
A scientist, innovator, and educator, Prof. Nazir has developed several wellness protocols that are now internationally recognized. His work during the COVID-19 pandemic was particularly noteworthy, as he played a significant role in assisting the African community, which faced severe challenges due to limited resources. One of Prof. Nazir’s most significant contributions to the field of wellness is his reshaping of the REGENactive protocol and technology. This advancement is considered to be 500 years ahead of its time, offering a revolutionary approach to natural healing that integrates the latest in medical technology with the body’s inherent healing capabilities. Prof. Nazir’s mission is to help people heal naturally, believing that each individual’s commitment to a healthy lifestyle can collectively contribute to a healthier world. His work is driven by a passion for improving the quality of life for people around the globe, and he continues to advance his research and advocacy in wellness through his association with UIPM Singapore.
Prof. Dr. Md. Bipul Nazir is not just a wellness advisor but a pioneer in the fields of REGENactive therapy and longevity. His contributions have significantly advanced our understanding of human health, offering hope for a future where long, healthy, and fulfilling lives are the norm.
Mohd Hafiz
Hafiz is a software developer and a skilled professional with extensive experience in delivering tailored solutions and mobile app development. Specializing in responsive websites, custom applications, and e-commerce platforms, he ensures every project is optimized for performance and user experience.
As a seasoned Flutter developer, he creates high-quality, cross-platform mobile apps that drive business success. His approach combines technical excellence with creativity, crafting unique digital experiences that align with clients’ goals. Whether you need a website overhaul, custom development, e-commerce platforms, or a mobile app, he is committed to turning your vision into reality.
GILMS is privilege to have him as our CTO.
Dr Effat Un Nesa
Dr. Effat Un Nesa holds a Ph.D. in Radiation Oncology from Qilu Hospital, affiliated with Shandong University Cheeloo College of Medicine.
As a Radiation Oncologist, she provides comprehensive clinical care to patients, specializing in advanced radiation techniques such as external beam radiotherapy, intensity-modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and stereotactic body radiation therapy (SBRT). She has had the privilege of serving a diverse community, ensuring both personal and professional fulfillment in patient care.
In her role, she develops and prescribes individualized treatment plans for cancer patients, closely monitors their progress, and makes necessary adjustments to ensure they receive high-quality care throughout their treatment journey.